Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study

[1]  J. Burke,et al.  Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. , 2021, The New England journal of medicine.

[2]  T. Tsuzuki,et al.  Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma , 2021, International Journal of Clinical Oncology.

[3]  Travis L. Rice-Stitt,et al.  Updates in Staging and Reporting of Genitourinary Malignancies. , 2020, Archives of pathology & laboratory medicine.

[4]  I. Derweesh,et al.  Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma , 2019, Journal of oncology.

[5]  T. Powles,et al.  Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis. , 2018, European urology.

[6]  D. Heng,et al.  Prognostication in Kidney Cancer: Recent Advances and Future Directions. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Alsharedi,et al.  Check point inhibitors a new era in renal cell carcinoma treatment , 2018, Medical Oncology.

[8]  T. Choueiri,et al.  Evaluation of disease‐free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial‐level meta‐analysis , 2018, Cancer.

[9]  R. Bourgon,et al.  TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.

[10]  H. Kohrt,et al.  Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients , 2014, Nature.

[11]  J. Cheville,et al.  Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  N. Rioux-Leclercq,et al.  Prognostic ability of simplified nuclear grading of renal cell carcinoma , 2007, Cancer.

[13]  J. Lam,et al.  Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. , 2005, The Journal of urology.

[14]  Christian Coulange,et al.  Prognostic value of nuclear grade of renal cell carcinoma , 1995, Cancer.

[15]  Ron Brookmeyer,et al.  A Confidence Interval for the Median Survival Time , 1982 .

[16]  J. Cheville,et al.  Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[18]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .